Hanmi Pharm. financials at a glance

+ Portfolio

The revenue of Hanmi Pharm. is reported as 1468.18901 billion Won in the fiscal year 2023. The earnings were 10866.67 Won per share in 2023, which was 51.69 higher than 2021. And about 199.70588 billion Won are reported as free cash flow in the financials of Hanmi Pharm. 2023. Dividends of 488.7 Won per share were paid to shareholders of Hanmi Pharm. stock KOSE:A128940 in fiscal 2023.

₩1.33T

Revenue

₩7.99k

Earnings Per Share

53.96%

Gross Margin %

₩131.89B

Free Cash Flow

Revenue

1,331,721.00

Earnings Per Share

7,994.12

Gross Margin %

53.96

Free Cash Flow

131,890.47

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2011	2010
Rev.	Revenue	N/A	₩1.33T	₩1.21T	₩1.08T	₩1.11T	₩1.02T	₩916.59B	₩882.72B	₩1.32T	₩761.28B	₩730.13B	₩606.19B	₩614.00B
GM %	Gross Margin %	54.76%	53.96%	52.59%	54.00%	56.79%	53.24%	56.56%	52.21%	69.74%	55.45%	56.99%	55.10%	56.79%
OM	Operating Margin	13.14%	11.56%	10.42%	4.55%	9.33%	8.23%	8.96%	3.03%	16.08%	4.53%	8.48%	3.50%	-1.13%
EPS	Earnings Per Share	₩10.55k	₩7.99k	₩5.27k	₩939.50	₩4.17k	₩1.99k	₩4.87k	₩1.95k	₩12.07k	₩2.94k	₩4.04k	₩118.51	₩-,473.79
Div.	Dividends	N/A	₩490.20	₩480.58	₩471.16	₩461.92	₩452.87	₩443.99	₩1.74k	₩0.00	₩0.00	₩0.00	₩0.00	₩410.14
PR %	Payout Ratio %	0	6.13%	9.12%	50.15%	11.08%	22.72%	9.12%	89.21%	0.00%	0.00%	0.00%	0.00%	-86.57%
Sha.	Shares	N/AM	12.7M	12.47M	12.48M	12.49M	12.5M	12.51M	11.95M	12.55M	12.2M	10.88M	10.89M	10.9M
OCF	Operating Cash Flow	N/A	₩162.27B	₩201.92B	₩151.53B	₩12.45B	₩25.98B	₩-62,905.20M	₩412.97B	₩101.71B	₩-32,819.71M	₩0.00M	₩61.30B	₩34.94B
FCF	Free Cash Flow	N/A	₩131.89B	₩181.97B	₩109.72B	₩-,153,684.70M	₩-,156,285.75M	₩-,309,959.08M	₩212.71B	₩-19,352.73M	₩-,101,998.70M	₩0.00M	₩41.75B	₩-3,443.23M
FCFS	Free Cash Flow Per Share	₩7.51k	₩8.96k	₩13.72k	₩7.66k	₩-14,060.18	₩-15,706.98	₩-28,900.64	₩17.49k	₩-3,024.52	₩-9,608.64	₩4.89k	₩3.08k	₩-1,223.85

Hanmi Pharm. financials at a glance

Financials

Discover